Latest News and Press Releases

PHILADELPHIA, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA — (November 21, 2024) — The Wistar Institute’s Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center’s...

Philadelphia, PA, Oct. 03, 2024 (GLOBE NEWSWIRE) -- New findings could lead to different research tactics for scientists investigating a cure for HIV. Results from The Wistar Institute’s Lieberman...

PHILADELPHIA, PA, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The Wistar Institute’s President and CEO, Dario C. Altieri, M.D., and team have demonstrated the role of Parkin — a protein implicated in...

PHILADELPHIA, PA, July 17, 2024 (GLOBE NEWSWIRE) -- The Wistar Institute — building on its history of leading advances in human health as the nation’s first nonprofit biomedical research institute —...

PHILADELPHIA, PA, June 04, 2024 (GLOBE NEWSWIRE) -- Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only...

PHILADELPHIA, PA, May 28, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA — (May 28, 2024) — The Wistar Institute’s Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author,...

PHILADELPHIA, PA, May 14, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA — (May 14, 2024) — The Wistar Institute was awarded a $649,971 grant from the National Science Foundation (NSF) to support the...

PHILADELPHIA, PA, May 03, 2024 (GLOBE NEWSWIRE) -- The Wistar Institute assistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma — a serious and often...

PHILADELPHIA, PA, April 30, 2024 (GLOBE NEWSWIRE) -- Hepatocellular carcinoma (HCC), or liver cancer, is an aggressive malignancy with limited treatment options. An immunologically cold cancer —...

PHILADELPHIA, PA, April 10, 2024 (GLOBE NEWSWIRE) -- The Wistar Institute’s associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities...